In 2013, ESMO approached MCI about its plan to create and launch a Congress in Asia. It wanted to provide access to the latest science to its members and the wider oncology community in Asia, but also wanted to ensure it did not compete with regional congresses. The ESMO Asia Congress, was successfully launched in 2015 in Singapore and it is now a fixed feature in the ESMO repertoire of leading scientific meetings.
MCI Singapore reached out with a thorough research of the market opportunity, expected growth, need and costs basis. After 2 visits to Singapore ESMO and MCI agreed to a unique partnership arrangement, showing great confidence in MCI’s regional capability to achieve the required Industry support. After 3 successful editions, ESMO Asia has established itself as a global programme comparable to the European based congress.Download PDF